Website News and Research

RSS

NAACP endorses optometric vision therapy at its 100th Anniversary Convention

A routine visit to the eye doctor resulted in a national resolution that was passed by the NAACP at its 100th Anniversary Convention held in New York City, endorsing optometric vision therapy as a way to help some prisoners become productive members of society.

1 Oct 2009

CHCC announces the filing of SEC Form 15

China Health Care Corporation announced that the Company filed a Form 15 as notice of suspension of the duty to file periodic reports under Sections 13 and 15(d) of the Securities Exchange Act of 1934 with the Securities and Exchange Commission ("SEC") on September 29, 2009. The Company is, thereby, voluntarily suspending its reporting obligations under the Securities Exchange Act of 1934.

1 Oct 2009

Respiragene test for lung cancer motivates smokers to quit smoking

Smokers who learn their personal risk of lung cancer through gene-based risk assessment are more likely to be motivated to quit their habit, according to Dr. W. Jeffrey Allard, clinical affairs director of Synergenz Bioscience Ltd.

1 Oct 2009

New online platform help physicians make informed decisions about e-prescription

Informed Decisions, LLC, a leading developer of drug information applications and clinical information solutions, announced today that it is providing information about its leading e-prescribing solution via the American Medical Association's (AMA) new ePrescribing Learning Center.

30 Sep 2009

Disaster preparedness program on UCTV

Earthquakes, fires, floods, pandemics. The public relies on health professionals, emergency responders and trained volunteers to react appropriately to a range of disasters, big or small. But does everyone understand the systems that are in place to respond to these dreaded events?

30 Sep 2009

Offer period for conversion of bonds extended by Pharming

Biotech company Pharming Group NV ("Pharming" or the "Company") has received commitment from bondholders, representing 70% of the nominal amount of the currently outstanding bonds, to accept the offer to convert the bonds as announced on September 21, 2009. Together, they exceed the threshold level of 60% which Pharming set as a minimum participation in order to execute the transaction.

30 Sep 2009

Prevalence and emotional impact of hair pulling

1.5% of males and 3.4% of females in a college sample reported significant hair pulling resulting in bald patches at some point in their lives.

30 Sep 2009

Aetna announces first-dollar coverage for H1N1 flu vaccine administration

Aetna announced today that it will provide first-dollar coverage for the administration of the H1N1 flu vaccine for all of its fully-insured health plan members, and for all members of self-funded plans unless directed otherwise by the plan sponsor. Aetna is offering this coverage even in instances where members’ plans do not include coverage for preventive care or have limits on such coverage.

30 Sep 2009

San Francisco Medical Center acquires a BSD-500 Hyperthermia System

BSD Medical Corporation announced today that the University of California, San Francisco Medical Center (UCSF) has acquired a BSD-500 Hyperthermia System (BSD-500). UCSF is a world leader in hyperthermia and has the largest and most versatile hyperthermia program on the West Coast, and its world-renowned Radiation Oncology team has added the capabilities of the BSD-500 to its growing hyperthermia cancer treatment program.

29 Sep 2009

NovoCure initiates newly-diagnosed GBM clinical trial

NovoCure, Ltd., a privately held medical device company focused on developing the Novo-TTF device, a non-invasive portable medical device for the treatment of cancer, announced the completion of a new funding round today. Key investors in this round included Pfizer Inc, Johnson & Johnson Development Corporation and Index Ventures.

29 Sep 2009

Congressional reception raises awareness about breast cancer in young adult women

Testing for breast cancer risk was the subject of remarks by two featured speakers at a recent congressional reception on Capitol Hill. The event generated momentum to pass the EARLY Act and raise awareness about breast cancer in young adult women.

29 Sep 2009

IOF awards the Linda Edwards Memorial Award to AFI

The International Osteoporosis Foundation (IOF) has awarded its prestigious 'IOF Linda Edwards Memorial Award' to the Arthritis Foundation of India Trust (AFI), one of 193 IOF member societies around the world. The award was presented today at the IOF Worldwide Osteoporosis Patient Society Conference, being held from September 22-25, 2009 in Beijing, China.

28 Sep 2009

New Fragment Screening Platform from Selcia

Selcia Ltd, a worldwide industry leading C-14 custom radiolabelling provider and drug discovery company this week launched their new Fragment Screening Platform and unveiled their new brand as part of ambitious international expansion plans.

28 Sep 2009

BIOLASE to market its Waterlase MD products in China

BIOLASE Technology, Inc. today announced that it finalized three regional distribution agreements in the People's Republic of China. This announcement follows the Company's August 12, 2009, announcement that it had received regulatory approval to market its Waterlase MD™ products in China.

28 Sep 2009

Dyax to present an update of its clinical development programs

Dyax Corp., a developer of novel biotherapeutics for unmet medical needs, announced today that Gustav A. Christensen, President and Chief Executive Officer of Dyax, will present at the Fourth Annual JMP Securities Healthcare Focus Conference, being held October 5-6th at The New York Palace Hotel in New York City, NY.

25 Sep 2009

Entertainment Arts Research to acquire Explain My Surgery

Entertainment Arts Research, Inc. (EARI) today announced that they have issued a letter of intent to acquire Explain My Surgery, Inc. (EMS) and have the company become a wholly-owned subsidiary of EARI.

25 Sep 2009

Vertex Pharmaceuticals to present SVR data at the 60th Annual Meeting of the American Association

Vertex Pharmaceuticals Incorporated today announced that sustained virologic response (SVR) data from Study C208, which evaluated twice-daily dosing of Vertex’s investigational hepatitis C virus (HCV) protease inhibitor telaprevir, will be presented in an oral presidential plenary session at the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) taking place Oct. 30 – Nov. 3, 2009 in Boston.

25 Sep 2009

Students live with elder residents as part of the Learning by Living project

A geriatric training method pioneered by Marilyn R. Gugliucci, PhD, president of the Association for Gerontology in Higher Education (the educational branch of The Gerontological Society of America) has proved successful enough that she plans to implement it on a national level.

25 Sep 2009

Jean-Pol Tassin honored with the ECNP Neuropsychopharmacology Award

The European College of Neuropsychopharmacology (ECNP) is pleased to announce Jean-Pol Tassin as the recipient of the 2009 ECNP Neuropsychopharmacology Award in Basic Science Research in recognition of his pioneering and innovative research into the neurochemical basis of substance addiction.

24 Sep 2009

"Top Docs" ad campaign suit resolved

Virtua may continue advertising that it has the most Top Docs as a result of a Consent Order agreed to by the parties in the suit brought by Cooper against Virtua in February 2009.

24 Sep 2009